Lead Finding for Acetyl Cholinesterase Inhibitors from Natural Origin: Structure Activity Relationship and Scope
Overview
Affiliations
Acetylcholinesterase (AChE) inhibitors are considered as promising therapeutic agents for the treatment of several neurological disorders such as Alzheimer's disease (AD), senile dementia, ataxia and myasthenia gravis. There are only few synthetic medicines with adverse effects, available for treatment of cognitive dysfunction and memory loss associated with these diseases. A variety of plants has been reported to possess AChE inhibitory activity and so may be relevant to the treatment of neurodegenerative disorders such as AD. Hence, developing potential AChE inhibitors from botanicals is the need of the day. This review will cover some of the promising acetylcholinesterase inhibitors isolated from plants with proven in vitro and in vivo activities with concern to their structure activity relationship.
Chen S, Wei B, Fu Y Int J Mol Sci. 2023; 24(9).
PMID: 37175683 PMC: 10177984. DOI: 10.3390/ijms24097972.
Inhibition of Acetylcholinesterase by Novel Lupinine Derivatives.
Schepetkin I, Nurmaganbetov Z, Fazylov S, Nurkenov O, Khlebnikov A, Seilkhanov T Molecules. 2023; 28(8).
PMID: 37110594 PMC: 10146204. DOI: 10.3390/molecules28083357.
Senol Deniz F, Eren G, Orhan I, Sener B, Ozgen U, Aldaba R Molecules. 2021; 26(7).
PMID: 33916300 PMC: 8037418. DOI: 10.3390/molecules26072024.
Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview.
Libro R, Giacoppo S, Rajan T, Bramanti P, Mazzon E Molecules. 2016; 21(4):518.
PMID: 27110749 PMC: 6274085. DOI: 10.3390/molecules21040518.
Zdarova Karasova J, Hroch M, Musilek K, Kuca K Neurotox Res. 2015; 29(2):267-74.
PMID: 26646154 DOI: 10.1007/s12640-015-9582-4.